We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$214M
AUM Growth
+$4.1M
Cap. Flow
-$758K
Cap. Flow %
-0.35%
Top 10 Hldgs %
10.99%
Holding
242
New
22
Increased
21
Reduced
29
Closed
23

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$2.67M
2
XOM icon
ExxonMobil
XOM
+$1.63M
3
CRM icon
Salesforce
CRM
+$1.48M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.45M
5
AMZN icon
Amazon
AMZN
+$1.42M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 14.4%
3 Healthcare 14.07%
4 Industrials 12.13%
5 Consumer Discretionary 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$161B
$1.38M 0.64%
16,498
-757
-4% -$67.2K
FIZZ icon
27
National Beverage
FIZZ
$2.87B
$1.38M 0.64%
43,790
PRAA icon
28
PRA Group
PRAA
$648M
$1.32M 0.62%
54,717
REGN icon
29
Regeneron Pharmaceuticals
REGN
$68.8B
$1.32M 0.62%
3,770
+1,000
+36% +$385K
LGIH icon
30
LGI Homes
LGIH
$1.4B
$1.31M 0.61%
41,100
UAA icon
31
Under Armour
UAA
$3B
$1.3M 0.61%
32,530
+21,315
+190% +$847K
COF icon
32
Capital One
COF
$124B
$1.3M 0.61%
20,539
+4,162
+25% +$290K
MGNX icon
33
MacroGenics
MGNX
$235M
$1.29M 0.6%
47,737
LOCK
34
DELISTED
LifeLock, Inc.
LOCK
$1.28M 0.6%
81,161
URBN icon
35
Urban Outfitters
URBN
$5.99B
$1.28M 0.6%
46,457
+23,000
+98% +$661K
STZ icon
36
Constellation Brands
STZ
$22.2B
$1.27M 0.6%
7,704
-3,828
-33% -$599K
VASC
37
DELISTED
Vascular Solutions Inc
VASC
$1.24M 0.58%
29,709
CMG icon
38
Chipotle Mexican Grill
CMG
$40.8B
$1.23M 0.58%
152,900
+22,100
+17% +$192K
MASI
39
DELISTED
Masimo
MASI
$1.23M 0.58%
23,427
COST icon
40
Costco
COST
$415B
$1.23M 0.57%
7,808
-2,200
-22% -$333K
AXON
41
Axon Enterprise
AXON
$40.5B
$1.22M 0.57%
48,883
GE icon
42
GE Aerospace
GE
$367B
$1.22M 0.57%
+8,063
New +$1.18M
MDSO
43
DELISTED
Medidata Solutions, Inc.
MDSO
$1.21M 0.57%
25,805
LHCG
44
DELISTED
LHC Group LLC
LHCG
$1.17M 0.55%
27,120
KMI icon
45
Kinder Morgan
KMI
$73.1B
$1.16M 0.54%
62,200
+13,000
+26% +$232K
HSTM icon
46
HealthStream
HSTM
$793M
$1.16M 0.54%
43,814
SJM icon
47
J.M. Smucker
SJM
$12.6B
$1.15M 0.54%
7,533
-2,172
-22% -$289K
DPLO
48
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.15M 0.54%
32,768
ISRG icon
49
Intuitive Surgical
ISRG
$121B
$1.14M 0.53%
+15,471
New +$1.09M
DHR icon
50
Danaher
DHR
$135B
$1.14M 0.53%
16,728

Similar funds

Capital Impact Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Capital Impact Advisors held 242 positions worth $214M, up 2% from $210M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Capital Impact Advisors's Q2 2016 filing shows 22 new, 21 increased, 29 reduced and 23 closed positions. Its largest new stake was ExxonMobil: 18,463 shares worth $1.73M. The largest sale was Jazz Pharmaceuticals, an estimated $1.78M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Capital Impact Advisors's largest Q2 2016 buy was ExxonMobil: 18,463 shares worth $1.73M.
  • Capital Impact Advisors added most to United Therapeutics in Q2 2016, an estimated $2.67M increase.
  • Capital Impact Advisors's biggest Q2 2016 reduction was Jazz Pharmaceuticals, cutting an estimated $1.78M.
  • Capital Impact Advisors fully exited Charles Schwab in Q2 2016, selling an estimated $1.56M.
  • Capital Impact Advisors's ten largest holdings make up 11% of its $214M portfolio in Q2 2016.
  • Capital Impact Advisors opened 22 new positions and closed 23 in Q2 2016.
  • Capital Impact Advisors's portfolio value rose 2% quarter-over-quarter to $214M.

Based on Capital Impact Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.